Suppr超能文献

通过液体活检将微小RNA谱作为肺腺癌生物标志物的研究趋势:一项文献计量分析。

Research trends in microRNA profiling as a biomarker for lung adenocarcinoma via liquid biopsy: A bibliometric analysis.

作者信息

Kartika Aprilia I, Dafip Muchamad, Wijayanti Nastiti, Heriyanto Didik S, Haryana Sofia M, Taroeno-Hariadi Kartika W

机构信息

Biotechnology Doctorate Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Department of Medical Laboratory Technology, Faculty of Health and Nursing, Universitas Muhammadiyah Semarang, Semarang, Indonesia.

出版信息

Narra J. 2025 Apr;5(1):e1372. doi: 10.52225/narra.v5i1.1372. Epub 2025 Jan 16.

Abstract

Research related to the development of diagnostic biomarkers in lung adenocarcinoma in various countries is important. Research on microRNA as a biomarker in lung adenocarcinoma varies depending on the population, specimen, and technology used for profiling and validation. The aim of this study was to map and analyze bibliometric data of publications related to the topic of microRNA as a candidate biomarker in lung adenocarcinoma and to determine any potential research gaps. A total of 8,506 articles were collected from Crossref, Google Scholar, Semantic Scholar, PubMed, and Scopus databases using Harzing's Publish or Perish platform. A systematic search was conducted using four keywords: "profiling," "validating," "microRNA," and "lung adenocarcinoma," and synonyms of these keywords based on the MeSH on NCBI. The data extraction process followed the chart from PRISMA-P. The article's elimination was conducted using Mendeley Desktop and then was analyzed based on the authors' keywords using VOSviewer and Biblioshiny. A bibliometric analysis of 692 relevant articles identified four primary research clusters: (1) microRNA (19 keywords), which highlights its potential as a biomarker for early detection and diagnosis; (2) lung adenocarcinoma (18 keywords), reflecting advancements in lung cancer research; (3) liquid biopsy (19 keywords), emphasizing the growing interest in non-invasive diagnostic methods; and (4) bioinformatics (nine keywords), underscoring the role of computational approaches in transcriptomic analysis. As a primary topic, microRNAs have become a focal point of research for diagnosing lung cancer across various stages and as biomarkers for cancer cell proliferation, invasion, migration, and metastasis. Numerous studies have demonstrated the successful application of microRNAs in lung cancer diagnosis in the last decade, although the reported types of microRNAs are inconsistent. Therefore, further research on this topic should be continuously conducted, particularly to validate the types of microRNAs and the types of environments that influence them.

摘要

各国有关肺腺癌诊断生物标志物开发的研究很重要。作为肺腺癌生物标志物的微小RNA研究因用于分析和验证的人群、样本及技术不同而存在差异。本研究的目的是绘制并分析与微小RNA作为肺腺癌候选生物标志物这一主题相关的文献计量数据,并确定任何潜在的研究空白。使用哈津的“发表或灭亡”平台从CrossRef、谷歌学术、语义学者、PubMed和Scopus数据库中总共收集了8506篇文章。使用四个关键词进行系统检索:“分析”“验证”“微小RNA”“肺腺癌”,以及基于美国国立医学图书馆(NCBI)的医学主题词表(MeSH)的这些关键词的同义词。数据提取过程遵循PRISMA-P的流程图。使用Mendeley Desktop进行文章筛选,然后使用VOSviewer和Biblioshiny基于作者的关键词进行分析。对692篇相关文章的文献计量分析确定了四个主要研究集群:(1)微小RNA(19个关键词),突出了其作为早期检测和诊断生物标志物的潜力;(2)肺腺癌(18个关键词),反映了肺癌研究的进展;(3)液体活检(19个关键词),强调了对非侵入性诊断方法日益增长的兴趣;(4)生物信息学(9个关键词),强调了计算方法在转录组分析中的作用。作为一个主要主题,微小RNA已成为诊断各阶段肺癌以及作为癌细胞增殖、侵袭、迁移和转移生物标志物研究的焦点。在过去十年中,许多研究已经证明微小RNA在肺癌诊断中的成功应用,尽管所报道的微小RNA类型并不一致。因此,应持续开展关于该主题的进一步研究,特别是要验证微小RNA的类型以及影响它们的环境类型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验